First Site in Japan to Install Stereotaxis Technology Completes 250 Procedures
“After being introduced to the Niobe system, I made it a personal goal to be the first physician to bring the next generation of cardiac ablation therapy to the people of Japan,” said
Dr. Yamashiro shared the example of a patient who had suffered from atrial tachycardia for 10 years, which could not be corrected with repeated manual ablation approaches. “With the Niobe system, we were able to completely cure the patient in a single procedure,” he said. “This technology has given us the unique ability to navigate an ablation catheter inside the heart with extreme precision for more exact lesion creation, and with significantly reduced radiation exposure to our patients and staff.”
“Our heart rhythm management services have been greatly enhanced by the important benefits of remote magnetic navigation technology, which has been well received across the region. We are delighted to deliver such an exciting innovation,” continued Dr. Yamashiro.
Takatsuki General Hospital underwent a complete renovation in 2015 to support the latest medical advances, such as the Niobe system, and provide higher quality, more integrated patient services. The first procedures with the Niobe system were performed in July of that year.
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in
David FischelChairman and Acting Chief Executive Officer 314-678-6101 Martin C. StammerChief Financial Officer 314-678-6155